Matched control study of efficacy of lymphocyte immunotherapy in donor oocyte recipients to support or refute the concept of need for histocompatibility antigen sharing of the couple for benefits

Clinical and Experimental Obstetrics and Gynecology

Volumn 32, Issue 3, 2005, Pages 155-157

  Check, J H ^a,b   Liss, J R ^a   Diantonio, A ^a   Check, M L ^a   Duroseau, M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Donor oocytes; Immunotherapy; Lymphocytes; Recipients

Indexed keywords

HISTOCOMPATIBILITY ANTIGEN; LYMPHOCYTE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; CONCEPTION; EMBRYO TRANSFER; EVALUATION; FEMALE; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOTHERAPY; LYMPHOCYTE IMMUNOTHERAPY; LYMPHOCYTE TRANSFER; MALE; OOCYTE; OOCYTE DONATION; OOCYTE RECIPIENT; OUTCOMES RESEARCH; PREGNANCY; TREATMENT FAILURE;

CASE-CONTROL STUDIES; EMBRYO TRANSFER; FEMALE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNOTHERAPY; INFERTILITY, FEMALE; LYMPHOCYTES; MALE; OOCYTES; PREGNANCY; PREGNANCY RATE;

EID: 28044452863     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Check J.H., Liss J.R., Check M.L., Diantohio A., Duroseau M.: "Lymphocyte immunotherapy can improve pregnancy outcome following embryo transfer (ET) in patients failing to conceive after two previous ETs". Clin. Exp. Obstet. Gynecol., 2005, 32, 21.
2. Check J.H., Liss J., Check M.L., Diantonio A., Choe J.K., Graziano V.: "Leukocyte immunotherapy improves live delivery rates following embryo transfer in women with at least two previous failures - A retrospective review". Clin. Exp. Obstet. Gynecol., 2005, in press.
3. Christiansen O.B.: "The possible role of classical human leukocyte antigens in recurrent miscarriage". Am. J. Reprod. Immunol., 1999, 42, 110.
4. Ober C., Steck T., van der Ven K., Bilstrand C., Messer L., Kwak J. et al.: "MHC class II compatibility in aborted fetuses and term infants of couples with recurrent spontaneous abortion". J. Reprod. Immunol., 1993, 25, 195.
5. Wagenknecht D.R., Green K.M., McIntyre J.A.: "Analysis of HLA-DQ alleles in recurrent spontaneous abortion (RSA) couples". Am. J. Reprod. Immunol., 1997, 37, 1.
6. Laitinen T, Koskimies S., Westman P.: "Foeto-maternal compatibility in HLA-DR-DQ and -DP loci in Finnish couples suffering from recurrent spontaneous abortions'. Euro J. Immunogenet., 1993, 20, 249.
7. Christiansen O.B., Rasmussen K.L., Jersild C., Grunnet N.: "HLA class II alleles confer susceptibility to recurrent fetal losses in Danish women". Tissue Antigens, 1994, 44, 225.
8. Check J.H., Arwitz M., Gross J., Peymer M., Szekeres-Bartho J.: "Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)". Am. J. Reprod. Immunol., 1997, 37, 17.
9. Szekeres-Bartho J., Autran B., Debre P., Andreu G., Denver L., Chaouat G.: "Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction". Cell Immunol., 1989, 122, 281.
10. Szekeres-Bartho J., Kilar F., Falkay G., Csernus V., Torok A., Pacsa A.S.: "The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis". Am. J. Reprod. Microbiol., 1985, 9, 15.
11. Szekeres-Bartho J., Barakonyi A., Polgar B., Par G., Faust Z., Palkovics T. et al.: "The role of gamma/delta T cells in progesterone-mediated immunomodulation during pregnancy: a review". Am. J. Reprod. Immunol., 1999, 42, 44.
12. Rai R., Sacks G., Trew G.: "Natural killer cells and reproductive failure - theory, practice and prejudice". Hum. Reprod., 2005, 20, 1123.
13. Thum M.Y., Bhaskaran S., Bansal A.S., Shehata H., Ford B., Sumar N., Abdalla H.I.: "Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome". Hum. Reprod., 2005, 20, 1272.
14. Check J.H., Choe J.K., Ubelacker L., DiAntonio A.: "Maternal/ paternal sharing of DQ-Alpha type II histocompatibility antigens not associated with pregnancy outcome following in vitro fertilization (IVF)-embryo transfer (ET)". Clin. Exp. Obst. Gyn., 2001, 28, 142.
15. Check J.H., Tarquini P., Gandy P., Lauer C.: "A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters". Gynecol. Obstet. Invest., 1995, 39, 257.